Navigation Links
New test shows promise for detecting warning signs of joint replacement failure
Date:4/27/2011

A new test shows promise for detecting the early stages of a major cause of failure in joint replacement implants, so that patients can be treated and perhaps avoid additional surgery. More than 1.5 million total joint replacement operations are performed worldwide each year. While the success rate is 90 per cent, almost 10 per cent of implants fail and require additional surgery, report appears in the ACS journal Molecular Pharmaceutics.

Dong Wang and colleagues at University of Nebraska Medical Center and the Hospital for Special Surgery of New York explain that wear and tear in a joint replacement can create tiny bits of debris that cause local inflammation and lead to bone loss. When this happens, the implant can become loose and set the stage for failure. Treatment usually comes too late, they note, since it's difficult to detect the problem in its early stages. "When pain or clear radiographic evidence is reported, unfortunately, considerable bone loss has already occurred, which cannot be easily restored," the scientists note.

To provide an early diagnostic tool for implant failure, the researchers developed a polymer-based system for imaging the inflammation that is associated with the wear debris. Their tests of the imaging agent in mouse bone suggest that it can help them detect the early stages of bone loss that might cause a joint implant to become loose. They also found that they could tether a powerful anti-inflammatory drug to the polymeric system, offering a way to treat inflammation and bone loss in these early stages of wear. "Subsequent therapeutic interventions at this stage," they write, "would permit prolongation of the lifetime of the implant with improved patient outcomes."


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Study shows how mosquitoes handle the heat of a hot blood meal
2. USC research shows critical role of placenta in brain development
3. Functional MRI shows how mindfulness meditation changes decision-making process
4. Polarized microscopy technique shows new details of how proteins are arranged
5. Periodontal stem cell transplantation shows promise
6. Soy increases effectiveness of radiation at killing lung cancer, Wayne State study shows
7. Chimpanzees contagious yawning evidence of empathy, not just sleepiness, study shows
8. Nanopolymer shows promise for helping reduce cancer side effects
9. Drought-exposed leaves adversely affect soil nutrients, study shows
10. Protein adaptation shows that life on early earth lived in a hot, acidic environment
11. Epidemiological tree study shows impacts of climate change on forests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a ... point-of-care products for the objective detection of concussion and ... company has successfully completed a meeting with the U.S. ... Tbit™ blood test Pre-Submission Package. During the meeting company ... system as a precursor to commencement of a planned ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
Breaking Biology News(10 mins):
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 /PRNewswire/ ... immune modulatory medicines, announced today the initiation of a ... candidate, LYC-30937- E nteric C oated, in patients ... that is estimated to affect as many as 7.5 million ... with approximately 1.5 - 3 million cases being diagnosed ...
Breaking Biology Technology: